tiprankstipranks
Replimune Group (REPL)
NASDAQ:REPL
Want to see REPL full AI Analyst Report?

Compare Replimune Group (REPL) vs. Competitors

507 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Replimune Group
$2.17
$206.43M
-3.16
-69.73%
0 Buy
4 Hold
3 Sell
Moderate Sell
Anavex Life Sciences
$3.64
$307.67M
-13.95
-63.57%
1 Buy
0 Hold
0 Sell
Moderate Buy
Arcus Biosciences
$24.25
$3.23B
-7.25
185.64%
8 Buy
2 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$10.75
$980.50M
-5.55
69.84%
10 Buy
0 Hold
0 Sell
Strong Buy
Nurix Therapeutics
$17.51
$1.74B
-5.04
50.22%
7 Buy
0 Hold
0 Sell
Strong Buy
Sana Biotechnology
$3.52
$872.65M
-4.22
80.42%
6 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
REPL
Replimune Group
3.03
-4.47
-59.60%
AVXL
Anavex Life Sciences
3.41
-4.82
-58.57%
RCUS
Arcus Biosciences
26.05
17.93
220.81%
ORIC
Oric Pharmaceuticals
9.63
4.59
91.07%
NRIX
Nurix Therapeutics
16.93
7.29
75.62%
SANA
Sana Biotechnology
3.41
1.70
99.42%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts